HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 41,450
-3,150 (-7.06%)
At close: Jul 3, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 297.45 billion as of July 2, 2026. Its market cap has increased by 93.53% in one year.
Market Cap
297.45B
Enterprise Value
304.70B
Revenue
14.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
41,450.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 297.45B, an increase of 160.52%. That is a compound annual growth rate of 78.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 297.45B | -9.17% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 700.70B |
| Samyang Biopharm | 364.36B |
| ImmuneOncia Therapeutics | 320.37B |
| NOVAREX | 226.90B |
| CellBion | 216.42B |
| DAE HWA Pharmaceutical | 179.90B |
| Vivozon Pharmaceutical | 153.42B |
| GC WellBeing | 151.01B |